ElevatION: CRC-101: A Phase Ib Study of PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 28 Nov 2017
At a glance
- Drugs PDR 001 (Primary) ; Bevacizumab; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ElevatION
- Sponsors Novartis Pharmaceuticals
- 21 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 16 Oct 2017 Status changed from not yet recruiting to recruiting.
- 08 Jun 2017 New trial record